Market Synopsis of Thymus Cancer Market:
Thymus cancer is a tumor formed on the outer surface originating from the epithelial cells of the thymus. Thymus is a small organ located in the upper chest under the breast bone and makes specific type of white blood cells which help the body fight infection. There are no prominent causes or risk factors for thymus cancer. Thymus cancer is an uncommon tumor, best known for its association with the neuromuscular disorder myasthenia gravis and is found in 20% of patients with myasthenia gravis. It is a rare type of cancer which accounts for only 1 % of total cancers. The tumor occurs at the rate of only 1.5 cases in million people each year in the United States. Once diagnosed, thymus cancer can be removed surgically. In the rare cases of a malignant tumor, chemotherapy may also be used. The market for thymus cancer is showing a limited growth. The global market for thymus cancer is expected to reach US$ Million by the end of the forecasted period and is expected to grow at a Strong CAGR.
Get Sample PDF Illustration @ https://www.marketresearchfuture.com/sample_request/1550
Latest Industry News
- 23 JUL 2018 Lili Yang, a researcher from the University of California (UCLA), has been awarded the US $1.4 mn to develop further, a stem cell-based cancer treatment that can treat various kinds of cancers including thymus cancer. After genetically modifying the stem cells from healthy donors, Yang’s new method places them in an artificial thymic organoid. The organoid replicates the functions of the thymus and helps convert blood-forming stem cells into immune cells.
- 24 JUL 2018 Following the transitioning of a T-cell therapy program, Adaptimmune received a $27.5 mn payment from GlaxoSmithKline. Adaptimmune’s NY-ESO SPEAR T-cell therapy technology boosts the ability of a person’s immune system to recognize and destroy cancer cells. SPEAR stands for specific peptide enhanced affinity receptor T-cells. T-cells are subtypes of white blood cells that develop in the thymus gland. They are responsible for a variety of immune system responses.
Key Players for Global Thymus Cancer Market
Market Research Future (MRFR) recognizes the following companies as the key players in Thymus Cancer Market: There are plenty of large and small market players which operate in this market all over the globe.
The key players the Global Thymus Cancer Market include Amgen Inc (USA), Astellas Pharma Inc (Japan), Astrazeneca (UK), Bristol-Myers Squibb (USA), Celgene Corporation (USA), Cellceutix Corporation (USA), Eli Lilly and Company (USA), Johnson & Johnson (USA), Merck & Co. Inc. (USA), Novartis AG (USA), Onxeo SA (France), Pfizer Inc (USA), Sumitomo Dainippon Pharma Co. Ltd. (Japan), Taiwan Liposome Company Ltd. (Taiwan), Takeda pharmaceutical company (Japan), Tiziana Life Sciences PLC (UK).
Segments for Global Thymus Cancer Market
The global thymus cancer market has been segmented on the basis of care centers, treatment, types, and lastly region. On the basis of care centers, this market has been segmented into clinics, diagnostic centers, hospitals, research laboratories and others. Based on treatment, the market has been segmented into chemotherapy, radiotherapy, surgery, and others. Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized regimen. Also known as radiation therapy, radiotherapy is a therapy that uses ionizing radiation. Generally, ionizing radiation is used as part of cancer treatment to control or kill malignant cells. Treatment is usually delivered by a linear accelerator. By types, the global thymus cancer market has been segmented into type A, type AB, type B1, type B2, type B3 and thymic carcinoma (type C). The thymus is made from different types of cells, and the types of thymus cancer damage the cells differently.
Regional Analysis for Global Thymus Cancer Market
The regional segmentation of the global thymus cancer market comprises of regions namely North America, Europe, Asia Pacific, and the rest of the world (RoW). Among these regional market, North America is the largest market due to most advanced medical facilities and treatment being available in this region. In this region, the cream of revenue comes from the United States of America and Canada. After North America, the second largest regional market is Europe. As medical facilities and treatment in Western Europe are more advanced compared to those in Eastern Europe, the countries driving the European market are France, Germany, Italy, Spain, and the United Kingdom (UK), followed by rest of Europe.
During the forecast period, Asia Pacific region is expected to grow significantly. In this region, due to the high density of population and the growing awareness about various kinds of cancer, demand for better medical facilities regarding all kinds of cancer including thymus cancer, there is huge scope for market growth in this region. Biggest markets in this market comprise of China, India, Japan and South Korea, followed by the rest of the Asia Pacific region. Although RoW segment includes the whole world, the primary market in this segment comprises of Africa and the Middle East. Due to lack of advanced medical facilities, limited education, and political instability, the market is small in this segment.
Do You Have Specific Requirement? Ask To Our Experts@ https://www.marketresearchfuture.com/enquiry/1550
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar